Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB.

Lee KH, Choi EY, Koh SA, Kim MK, Kim KO, Lee SH, Jang BI, Kim SW, Kim SW, Song SK, Choi JH, Kim JR.

Exp Mol Med. 2011 Sep 30;43(9):501-9.

2.

IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment.

Lee KH, Choi EY, Koh SA, Kim MK, Jang BI, Kim SW, Kim JR.

Oncol Rep. 2014 May;31(5):2123-30. doi: 10.3892/or.2014.3086. Epub 2014 Mar 12.

PMID:
24626561
3.

Hepatocyte growth factor-mediated gastrin-releasing peptide induces IL-8 expression through Ets-1 in gastric cancer cells.

Lee KH, Koh SA, Kim JR.

Oncol Res. 2013;20(9):393-402. doi: 10.3727/096504013X13657689382770.

PMID:
23924923
5.

Regulation of HGF-mediated cell proliferation and invasion through NF-κB, JunB, and MMP-9 cascades in stomach cancer cells.

Lee KH, Kim JR.

Clin Exp Metastasis. 2012 Mar;29(3):263-72. doi: 10.1007/s10585-011-9449-x. Epub 2012 Jan 18.

PMID:
22252121
6.

Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines.

Lee KH, Choi EY, Kim MK, Hyun MS, Jang BI, Kim TN, Kim SW, Song SK, Kim JH, Kim JR.

Exp Mol Med. 2006 Feb 28;38(1):27-35.

7.

Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.

Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH, Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, Choi I, Lee JH.

Cancer Res. 2003 Aug 1;63(15):4648-55.

8.

Urokinase type plasminogen activator and its receptor regulate the invasive potential of gastric cancer cell lines.

Okusa Y, Ichikura T, Mochizuki H, Shinomiya N.

Int J Oncol. 2000 Nov;17(5):1001-5.

PMID:
11029504
9.

Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.

Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.

Cancer Res. 2005 Sep 1;65(17):7775-81.

10.

Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.

Bauer TW, Fan F, Liu W, Johnson M, Parikh NU, Parry GC, Callahan J, Mazar AP, Gallick GE, Ellis LM.

Ann Surg. 2005 May;241(5):748-56; discussion 756-8.

11.

Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor.

Ried S, Jäger C, Jeffers M, Vande Woude GF, Graeff H, Schmitt M, Lengyel E.

J Biol Chem. 1999 Jun 4;274(23):16377-86.

12.

Semaphorin 5A promotes gastric cancer invasion/metastasis via urokinase-type plasminogen activator/phosphoinositide 3-kinase/protein kinase B.

Pan G, Zhu Z, Huang J, Yang C, Yang Y, Wang Y, Tuo X, Su G, Zhang X, Yang Z, Liu T.

Dig Dis Sci. 2013 Aug;58(8):2197-204. doi: 10.1007/s10620-013-2666-1. Epub 2013 May 10.

13.
14.

Hepatoma-derived growth factor regulates the bad-mediated apoptotic pathway and induction of vascular endothelial growth factor in stomach cancer cells.

Lee KH, Choi EY, Kim MK, Lee SH, Jang BI, Kim TN, Kim SW, Kim SW, Song SK, Kim JR, Jung BC.

Oncol Res. 2010;19(2):67-76.

PMID:
21302807
15.

Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target.

Lee KH, Choi EY, Hyun MS, Jang BI, Kim TN, Lee HJ, Eun JY, Kim HG, Yoon SS, Lee DS, Kim JH, Kim JR.

Clin Exp Metastasis. 2008;25(1):89-96. Epub 2007 Nov 9.

PMID:
17992475
16.

Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line.

Lengyel E, Gum R, Stepp E, Juarez J, Wang H, Boyd D.

J Cell Biochem. 1996 Jun 1;61(3):430-43.

PMID:
8761947
17.
18.

Geldanamycins exquisitely inhibit HGF/SF-mediated tumor cell invasion.

Xie Q, Gao CF, Shinomiya N, Sausville E, Hay R, Gustafson M, Shen Y, Wenkert D, Vande Woude GF.

Oncogene. 2005 May 26;24(23):3697-707.

PMID:
15782129
19.

[Effect of antisurvivin oligodeoxynucleotides on proliferation and apoptosis in gastric cancer cell line BGC-823 and the molecular mechanism].

Li Y, Fan LQ, Sun Y, Zhao Q, Tan BB, Liu Y.

Zhonghua Zhong Liu Za Zhi. 2011 Apr;33(4):265-9. Chinese.

PMID:
21575496
20.

RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer.

Koh SA, Kim MK, Lee KH, Kim SW, Kim JR.

Clin Exp Metastasis. 2014 Oct;31(7):805-15. doi: 10.1007/s10585-014-9671-4. Epub 2014 Sep 25.

PMID:
25253431

Supplemental Content

Support Center